Nastech Pharmaceutical Company Inc. has announced the presentation of data from its RNA interference therapeutic program for rheumatoid arthritis at the American College of Rheumatology Annual ...

Single-cell RNA sequencing (scRNA-seq ... critical for alternative mRNA splicing and translational control in rheumatoid arthritis (RA). How RBP regulation differs between RA and osteoarthritis ...

Rheumatoid arthritis, like many inflammatory diseases, is characterized by episodes of quiescence and exacerbation (flares). The molecular events leading to flares are unknown. We established a ...

Recent advances of biotechnology have laid the groundwork for potent and specific molecular-targeting therapies including RNA interference. The largest remaining hurdle for widespread use of this ...

Single-cell RNA sequencing (scRNA-seq ... critical for alternative mRNA splicing and translational control in rheumatoid arthritis (RA). How RBP regulation differs between RA and osteoarthritis ...

Scientists examining the blood of patients with rheumatoid arthritis (RA) have identified a never-before-seen cell type that could forewarn of worsening symptoms. The RNA sequencing studies ...

Studies of blood samples from four rheumatoid arthritis patients collected over years has led to the discovery of an RNA profile that predicts an imminent flare-up of symptoms, according to a report ...

RNA interference (RNAi) is a key biological process that leads to the silencing of gene expression. RNAi can be initiated by a cell in response to pathogenic nucleic acids to bring about a ...

Announcing a new publication for Acta Materia Medica journal. Single-cell RNA sequencing (scRNA-seq) data from published datasets were obtained to investigate the expression and dysregulation of ...